The FDA has approved Papzimeos™ (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis.

A fast-moving cholera outbreak in Sudan’s Darfur region has killed 40 people and sickened more than 2300 in the past week alone.

A Legionnaires’ disease outbreak in Central Harlem has now caused four deaths and sickened 101 people throughout New York City.

The FDA has accepted for Priority Review the supplemental NDA for gepotidacin in the treatment of uncomplicated urogenital gonorrhea.